Value Creation Process

Kitazato Corporation leverages its specialized technologies and experience in reproductive medicine as core strengths, while anticipating changes in society and evolving medical needs, to pursue the creation of sustainable value.

Through our business activities, we utilize a diverse range of “capitals,” including technological capital, human capital, trust capital, social capital, and natural/environmental capital, and are committed to creating social and economic value simultaneously in the field of reproductive medicine.

Our Six Value Capitals

Human Capital

Specialized expertise in reproductive medicine and craftsmanship in manufacturing processes.

Technological and Intellectual Capital

Cryopreservation technologies, precision processing of medical devices, and development of culture media and reagents.

Trust Capital

Collaboration with physicians, embryologists, and universities, as well as a global network of medical institutions in 110 countries.

Social and Mission Capital

Contribution to addressing the social challenge of infertility treatment.

Natural and Environmental Capital

Introduction of renewable energy, resource efficiency initiatives, and environmental considerations in reproductive medicine products.

Governance Capital

Quality assurance, risk management, and transparent management practices.

Value Creation Process

R&D (Research and Development)

• Advancement of cryopreservation technologies (including Cryotop).
• Formulation development for culture media and reagents.
• Precision processing technologies for catheters and ovum retrieval needles.
• Collaborative research with medical institutions.

Manufacturing (Made in Japan)

• Integrated production at the Shizuoka Headquarters Plant.
• Pursuit of high precision through microfabrication and manual processes.
• Compliance with international regulatory standards (FDA, CE, etc.).

Quality Assurance (QA)

• Rigorous inspections and stability evaluations.
• Collection of safety-related information and prompt responses.
• Thorough traceability.

Supply Chain and Stable Supply System

• Multiple sourcing and inventory strategies.
• A global logistics network.
• Business continuity planning (BCP) in the event of disasters.

Medical Support and Information Provision

• Guidance on proper use for physicians and embryologists.
• Collection of issues and feedback from clinical settings.
• Feedback on improvements and new product development.

Social Value (Outcomes)

• Improvement in treatment outcomes and fulfillment of patients’ hopes.
• Enhanced access to fertility treatment.
• Contribution to the global advancement of reproductive medicine.
• Contribution to environmental sustainability.
• Promotion of diversity and respect for human rights.

Long-Term Value (Long-Term Vision)

To become a global niche leader supporting reproductive medicine worldwide.

• Continuous technological innovation.
• Achieving both social and economic value.
• Leaving better medical care and a healthier global environment for future generations.